HUDSON EDGE INVESTMENT PARTNERS INC. - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 265 filers reported holding ROYALTY PHARMA PLC in Q4 2021. The put-call ratio across all filers is 0.25 and the average weighting 1.0%.

Quarter-by-quarter ownership
HUDSON EDGE INVESTMENT PARTNERS INC. ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q1 2023$486
+5.0%
13,482
+15.0%
0.15%
-4.4%
Q4 2022$463
-99.9%
11,7250.0%0.16%
-9.7%
Q3 2022$471,000
-4.5%
11,7250.0%0.18%
-2.8%
Q2 2022$493,000
+7.9%
11,7250.0%0.18%
+25.0%
Q1 2022$457,000
+2.9%
11,725
+5.2%
0.14%
+4.3%
Q4 2021$444,00011,1450.14%
Other shareholders
ROYALTY PHARMA PLC shareholders Q4 2021
NameSharesValueWeighting ↓
Siguler Guff Advisers, LLC 3,391,754$92,052,20447.04%
Indie Asset Partners, LLC 433,000$11,751,62011.84%
SUVRETTA CAPITAL MANAGEMENT, LLC 4,095,745$111,158,5196.01%
Advanced Portfolio Management, LLC 230,000$6,242,2005.25%
Compound Global Advisors, LLC 626,412$17,000,8223.73%
Geo Capital Gestora de Recursos Ltd 135,079$3,6663.39%
TORRAY INVESTMENT PARTNERS LLC 412,633$11,198,8601.98%
Overbrook Management Corp 298,712$8,107,0441.89%
Silicon Valley Community Foundation 358,270$9,723,4481.18%
Greytown Advisors Inc. 74,601$2,024,6711.12%
View complete list of ROYALTY PHARMA PLC shareholders